Global Immuno-oncology Therapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Immuno-oncology Therapy Market Size 2017-2028

2.1.2 Immuno-oncology Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Immuno-oncology Therapy Segment by Type

2.2.1 Monoclonal Antibodies

2.2.2 Immune Checkpoint Inhibitors

2.2.3 Immune System Modulators

2.2.4 Cancer Vaccines

2.3 Immuno-oncology Therapy Market Size by Type

2.3.1 Immuno-oncology Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Immuno-oncology Therapy Market Size Market Share by Type (2017-2022)

2.4 Immuno-oncology Therapy Segment by Application

2.4.1 Hospitals

2.4.2 Ambulatory Surgical Center

2.4.3 Others

2.5 Immuno-oncology Therapy Market Size by Application

2.5.1 Immuno-oncology Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Immuno-oncology Therapy Market Size Market Share by Application (2017-2022)

3 Immuno-oncology Therapy Market Size by Player

3.1 Immuno-oncology Therapy Market Size Market Share by Players

3.1.1 Global Immuno-oncology Therapy Revenue by Players (2020-2022)

3.1.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Immuno-oncology Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Immuno-oncology Therapy by Regions

4.1 Immuno-oncology Therapy Market Size by Regions (2017-2022)

4.2 Americas Immuno-oncology Therapy Market Size Growth (2017-2022)

4.3 APAC Immuno-oncology Therapy Market Size Growth (2017-2022)

4.4 Europe Immuno-oncology Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Immuno-oncology Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Immuno-oncology Therapy Market Size by Country (2017-2022)

5.2 Americas Immuno-oncology Therapy Market Size by Type (2017-2022)

5.3 Americas Immuno-oncology Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Immuno-oncology Therapy Market Size by Region (2017-2022)

6.2 APAC Immuno-oncology Therapy Market Size by Type (2017-2022)

6.3 APAC Immuno-oncology Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Immuno-oncology Therapy by Country (2017-2022)

7.2 Europe Immuno-oncology Therapy Market Size by Type (2017-2022)

7.3 Europe Immuno-oncology Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Immuno-oncology Therapy by Region (2017-2022)

8.2 Middle East & Africa Immuno-oncology Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa Immuno-oncology Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Immuno-oncology Therapy Market Forecast

10.1 Global Immuno-oncology Therapy Forecast by Regions (2023-2028)

10.1.1 Global Immuno-oncology Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Immuno-oncology Therapy Forecast

10.1.3 APAC Immuno-oncology Therapy Forecast

10.1.4 Europe Immuno-oncology Therapy Forecast

10.1.5 Middle East & Africa Immuno-oncology Therapy Forecast

10.2 Americas Immuno-oncology Therapy Forecast by Country (2023-2028)

10.2.1 United States Immuno-oncology Therapy Market Forecast

10.2.2 Canada Immuno-oncology Therapy Market Forecast

10.2.3 Mexico Immuno-oncology Therapy Market Forecast

10.2.4 Brazil Immuno-oncology Therapy Market Forecast

10.3 APAC Immuno-oncology Therapy Forecast by Region (2023-2028)

10.3.1 China Immuno-oncology Therapy Market Forecast

10.3.2 Japan Immuno-oncology Therapy Market Forecast

10.3.3 Korea Immuno-oncology Therapy Market Forecast

10.3.4 Southeast Asia Immuno-oncology Therapy Market Forecast

10.3.5 India Immuno-oncology Therapy Market Forecast

10.3.6 Australia Immuno-oncology Therapy Market Forecast

10.4 Europe Immuno-oncology Therapy Forecast by Country (2023-2028)

10.4.1 Germany Immuno-oncology Therapy Market Forecast

10.4.2 France Immuno-oncology Therapy Market Forecast

10.4.3 UK Immuno-oncology Therapy Market Forecast

10.4.4 Italy Immuno-oncology Therapy Market Forecast

10.4.5 Russia Immuno-oncology Therapy Market Forecast

10.5 Middle East & Africa Immuno-oncology Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Immuno-oncology Therapy Market Forecast

10.5.2 South Africa Immuno-oncology Therapy Market Forecast

10.5.3 Israel Immuno-oncology Therapy Market Forecast

10.5.4 Turkey Immuno-oncology Therapy Market Forecast

10.5.5 GCC Countries Immuno-oncology Therapy Market Forecast

10.6 Global Immuno-oncology Therapy Forecast by Type (2023-2028)

10.7 Global Immuno-oncology Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Amgen

11.1.1 Amgen Company Information

11.1.2 Amgen Immuno-oncology Therapy Product Offered

11.1.3 Amgen Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Amgen Main Business Overview

11.1.5 Amgen Latest Developments

11.2 AstraZeneca

11.2.1 AstraZeneca Company Information

11.2.2 AstraZeneca Immuno-oncology Therapy Product Offered

11.2.3 AstraZeneca Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 AstraZeneca Main Business Overview

11.2.5 AstraZeneca Latest Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Information

11.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Offered

11.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Bristol-Myers Squibb Main Business Overview

11.3.5 Bristol-Myers Squibb Latest Developments

11.4 Eli-Lilly

11.4.1 Eli-Lilly Company Information

11.4.2 Eli-Lilly Immuno-oncology Therapy Product Offered

11.4.3 Eli-Lilly Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Eli-Lilly Main Business Overview

11.4.5 Eli-Lilly Latest Developments

11.5 Roche

11.5.1 Roche Company Information

11.5.2 Roche Immuno-oncology Therapy Product Offered

11.5.3 Roche Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Roche Main Business Overview

11.5.5 Roche Latest Developments

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Company Information

11.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Offered

11.6.3 GlaxoSmithKline Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 GlaxoSmithKline Main Business Overview

11.6.5 GlaxoSmithKline Latest Developments

11.7 Janssen Biotech

11.7.1 Janssen Biotech Company Information

11.7.2 Janssen Biotech Immuno-oncology Therapy Product Offered

11.7.3 Janssen Biotech Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Janssen Biotech Main Business Overview

11.7.5 Janssen Biotech Latest Developments

11.8 Merck

11.8.1 Merck Company Information

11.8.2 Merck Immuno-oncology Therapy Product Offered

11.8.3 Merck Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Merck Main Business Overview

11.8.5 Merck Latest Developments

11.9 Novartis

11.9.1 Novartis Company Information

11.9.2 Novartis Immuno-oncology Therapy Product Offered

11.9.3 Novartis Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Novartis Main Business Overview

11.9.5 Novartis Latest Developments

11.10 Pfizer

11.10.1 Pfizer Company Information

11.10.2 Pfizer Immuno-oncology Therapy Product Offered

11.10.3 Pfizer Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Pfizer Main Business Overview

11.10.5 Pfizer Latest Developments

11.11 Sanofi

11.11.1 Sanofi Company Information

11.11.2 Sanofi Immuno-oncology Therapy Product Offered

11.11.3 Sanofi Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Sanofi Main Business Overview

11.11.5 Sanofi Latest Developments

11.12 Spectrum Pharmaceuticals

11.12.1 Spectrum Pharmaceuticals Company Information

11.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Offered

11.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Spectrum Pharmaceuticals Main Business Overview

11.12.5 Spectrum Pharmaceuticals Latest Developments

11.13 Takeda

11.13.1 Takeda Company Information

11.13.2 Takeda Immuno-oncology Therapy Product Offered

11.13.3 Takeda Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Takeda Main Business Overview

11.13.5 Takeda Latest Developments

11.14 BioNTech SE

11.14.1 BioNTech SE Company Information

11.14.2 BioNTech SE Immuno-oncology Therapy Product Offered

11.14.3 BioNTech SE Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 BioNTech SE Main Business Overview

11.14.5 BioNTech SE Latest Developments

11.15 Allogene Therapeutics

11.15.1 Allogene Therapeutics Company Information

11.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Offered

11.15.3 Allogene Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Allogene Therapeutics Main Business Overview

11.15.5 Allogene Therapeutics Latest Developments

11.16 IMAB-I-Mab Biopharma Co., Ltd.

11.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Information

11.16.2 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Offered

11.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 IMAB-I-Mab Biopharma Co., Ltd. Main Business Overview

11.16.5 IMAB-I-Mab Biopharma Co., Ltd. Latest Developments

11.17 Arcus Biosciences

11.17.1 Arcus Biosciences Company Information

11.17.2 Arcus Biosciences Immuno-oncology Therapy Product Offered

11.17.3 Arcus Biosciences Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Arcus Biosciences Main Business Overview

11.17.5 Arcus Biosciences Latest Developments

11.18 Gritstone Oncology

11.18.1 Gritstone Oncology Company Information

11.18.2 Gritstone Oncology Immuno-oncology Therapy Product Offered

11.18.3 Gritstone Oncology Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Gritstone Oncology Main Business Overview

11.18.5 Gritstone Oncology Latest Developments

11.19 Autolus Therapeutics

11.19.1 Autolus Therapeutics Company Information

11.19.2 Autolus Therapeutics Immuno-oncology Therapy Product Offered

11.19.3 Autolus Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Autolus Therapeutics Main Business Overview

11.19.5 Autolus Therapeutics Latest Developments

11.20 Rubius Therapeutics

11.20.1 Rubius Therapeutics Company Information

11.20.2 Rubius Therapeutics Immuno-oncology Therapy Product Offered

11.20.3 Rubius Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Rubius Therapeutics Main Business Overview

11.20.5 Rubius Therapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. Immuno-oncology Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Monoclonal Antibodies

Table 3. Major Players of Immune Checkpoint Inhibitors

Table 4. Major Players of Immune System Modulators

Table 5. Major Players of Cancer Vaccines

Table 6. Immuno-oncology Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Immuno-oncology Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Immuno-oncology Therapy Market Size Market Share by Type (2017-2022)

Table 9. Immuno-oncology Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Immuno-oncology Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Immuno-oncology Therapy Market Size Market Share by Application (2017-2022)

Table 12. Global Immuno-oncology Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Immuno-oncology Therapy Revenue Market Share by Player (2020-2022)

Table 14. Immuno-oncology Therapy Key Players Head office and Products Offered

Table 15. Immuno-oncology Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Immuno-oncology Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Immuno-oncology Therapy Market Size Market Share by Regions (2017-2022)

Table 20. Americas Immuno-oncology Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Immuno-oncology Therapy Market Size Market Share by Country (2017-2022)

Table 22. Americas Immuno-oncology Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Immuno-oncology Therapy Market Size Market Share by Type (2017-2022)

Table 24. Americas Immuno-oncology Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Immuno-oncology Therapy Market Size Market Share by Application (2017-2022)

Table 26. APAC Immuno-oncology Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Immuno-oncology Therapy Market Size Market Share by Region (2017-2022)

Table 28. APAC Immuno-oncology Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Immuno-oncology Therapy Market Size Market Share by Type (2017-2022)

Table 30. APAC Immuno-oncology Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Immuno-oncology Therapy Market Size Market Share by Application (2017-2022)

Table 32. Europe Immuno-oncology Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Immuno-oncology Therapy Market Size Market Share by Country (2017-2022)

Table 34. Europe Immuno-oncology Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Immuno-oncology Therapy Market Size Market Share by Type (2017-2022)

Table 36. Europe Immuno-oncology Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Immuno-oncology Therapy Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Immuno-oncology Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Immuno-oncology Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Immuno-oncology Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Immuno-oncology Therapy

Table 45. Key Market Challenges & Risks of Immuno-oncology Therapy

Table 46. Key Industry Trends of Immuno-oncology Therapy

Table 47. Global Immuno-oncology Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Immuno-oncology Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Immuno-oncology Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Immuno-oncology Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Immuno-oncology Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Immuno-oncology Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 53. Amgen Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 54. Amgen Immuno-oncology Therapy Product Offered

Table 55. Amgen Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Amgen Main Business

Table 57. Amgen Latest Developments

Table 58. AstraZeneca Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 59. AstraZeneca Immuno-oncology Therapy Product Offered

Table 60. AstraZeneca Main Business

Table 61. AstraZeneca Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. AstraZeneca Latest Developments

Table 63. Bristol-Myers Squibb Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 64. Bristol-Myers Squibb Immuno-oncology Therapy Product Offered

Table 65. Bristol-Myers Squibb Main Business

Table 66. Bristol-Myers Squibb Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Bristol-Myers Squibb Latest Developments

Table 68. Eli-Lilly Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 69. Eli-Lilly Immuno-oncology Therapy Product Offered

Table 70. Eli-Lilly Main Business

Table 71. Eli-Lilly Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Eli-Lilly Latest Developments

Table 73. Roche Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 74. Roche Immuno-oncology Therapy Product Offered

Table 75. Roche Main Business

Table 76. Roche Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Roche Latest Developments

Table 78. GlaxoSmithKline Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 79. GlaxoSmithKline Immuno-oncology Therapy Product Offered

Table 80. GlaxoSmithKline Main Business

Table 81. GlaxoSmithKline Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. GlaxoSmithKline Latest Developments

Table 83. Janssen Biotech Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 84. Janssen Biotech Immuno-oncology Therapy Product Offered

Table 85. Janssen Biotech Main Business

Table 86. Janssen Biotech Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Janssen Biotech Latest Developments

Table 88. Merck Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 89. Merck Immuno-oncology Therapy Product Offered

Table 90. Merck Main Business

Table 91. Merck Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Merck Latest Developments

Table 93. Novartis Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 94. Novartis Immuno-oncology Therapy Product Offered

Table 95. Novartis Main Business

Table 96. Novartis Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Novartis Latest Developments

Table 98. Pfizer Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 99. Pfizer Immuno-oncology Therapy Product Offered

Table 100. Pfizer Main Business

Table 101. Pfizer Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Pfizer Latest Developments

Table 103. Sanofi Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 104. Sanofi Immuno-oncology Therapy Product Offered

Table 105. Sanofi Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Sanofi Main Business

Table 107. Sanofi Latest Developments

Table 108. Spectrum Pharmaceuticals Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 109. Spectrum Pharmaceuticals Immuno-oncology Therapy Product Offered

Table 110. Spectrum Pharmaceuticals Main Business

Table 111. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Spectrum Pharmaceuticals Latest Developments

Table 113. Takeda Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 114. Takeda Immuno-oncology Therapy Product Offered

Table 115. Takeda Main Business

Table 116. Takeda Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Takeda Latest Developments

Table 118. BioNTech SE Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 119. BioNTech SE Immuno-oncology Therapy Product Offered

Table 120. BioNTech SE Main Business

Table 121. BioNTech SE Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. BioNTech SE Latest Developments

Table 123. Allogene Therapeutics Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 124. Allogene Therapeutics Immuno-oncology Therapy Product Offered

Table 125. Allogene Therapeutics Main Business

Table 126. Allogene Therapeutics Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Allogene Therapeutics Latest Developments

Table 128. IMAB-I-Mab Biopharma Co., Ltd. Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 129. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Offered

Table 130. IMAB-I-Mab Biopharma Co., Ltd. Main Business

Table 131. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. IMAB-I-Mab Biopharma Co., Ltd. Latest Developments

Table 133. Arcus Biosciences Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 134. Arcus Biosciences Immuno-oncology Therapy Product Offered

Table 135. Arcus Biosciences Main Business

Table 136. Arcus Biosciences Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 137. Arcus Biosciences Latest Developments

Table 138. Gritstone Oncology Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 139. Gritstone Oncology Immuno-oncology Therapy Product Offered

Table 140. Gritstone Oncology Main Business

Table 141. Gritstone Oncology Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 142. Gritstone Oncology Latest Developments

Table 143. Autolus Therapeutics Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 144. Autolus Therapeutics Immuno-oncology Therapy Product Offered

Table 145. Autolus Therapeutics Main Business

Table 146. Autolus Therapeutics Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 147. Autolus Therapeutics Latest Developments

Table 148. Rubius Therapeutics Details, Company Type, Immuno-oncology Therapy Area Served and Its Competitors

Table 149. Rubius Therapeutics Immuno-oncology Therapy Product Offered

Table 150. Rubius Therapeutics Main Business

Table 151. Rubius Therapeutics Immuno-oncology Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 152. Rubius Therapeutics Latest Developments

List of Figures

Figure 1. Immuno-oncology Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Immuno-oncology Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Immuno-oncology Therapy Market Size Market Share by Type in 2021

Figure 7. Immuno-oncology Therapy in Hospitals

Figure 8. Global Immuno-oncology Therapy Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Immuno-oncology Therapy in Ambulatory Surgical Center

Figure 10. Global Immuno-oncology Therapy Market: Ambulatory Surgical Center (2017-2022) & ($ Millions)

Figure 11. Immuno-oncology Therapy in Others

Figure 12. Global Immuno-oncology Therapy Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Immuno-oncology Therapy Market Size Market Share by Application in 2021

Figure 14. Global Immuno-oncology Therapy Revenue Market Share by Player in 2021

Figure 15. Global Immuno-oncology Therapy Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Immuno-oncology Therapy Market Size 2017-2022 ($ Millions)

Figure 17. APAC Immuno-oncology Therapy Market Size 2017-2022 ($ Millions)

Figure 18. Europe Immuno-oncology Therapy Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Immuno-oncology Therapy Market Size 2017-2022 ($ Millions)

Figure 20. Americas Immuno-oncology Therapy Value Market Share by Country in 2021

Figure 21. Americas Immuno-oncology Therapy Consumption Market Share by Type in 2021

Figure 22. Americas Immuno-oncology Therapy Market Size Market Share by Application in 2021

Figure 23. United States Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Immuno-oncology Therapy Market Size Market Share by Region in 2021

Figure 28. APAC Immuno-oncology Therapy Market Size Market Share by Application in 2021

Figure 29. China Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Immuno-oncology Therapy Market Size Market Share by Country in 2021

Figure 36. Europe Immuno-oncology Therapy Market Size Market Share by Type in 2021

Figure 37. Europe Immuno-oncology Therapy Market Size Market Share by Application in 2021

Figure 38. Germany Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Immuno-oncology Therapy Market Size Market Share by Application in 2021

Figure 46. Egypt Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Immuno-oncology Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 52. APAC Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 53. Europe Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 55. United States Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 56. Canada Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 59. China Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Japan Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 61. Korea Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 63. India Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Australia Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 65. Germany Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 66. France Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 67. UK Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Italy Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 69. Russia Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Spain Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 73. Israel Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Immuno-oncology Therapy Market Size 2023-2028 ($ Millions)